EP0520237A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Bone replacement material containing fibroblast growth factors
Assignee: Merck Patent GmbH
•
Filing: 1992-06-10
•
Granted: —
•
Expires: 2012-06-10
Abstract
Abstract Translated from German Die Erfindung betrifft ein Knochenersatzmaterial, das in einer porösen Matrix ein oder mehrere Polypeptide mit der biologischen Wirkung von Fibroblasten-Wachstumsfaktoren enthält. Das Einheilungsverhalten entspricht dem von autologem Knochentransplantat. The invention relates to a bone substitute material which contains one or more polypeptides with the biological effect of fibroblast growth factors in a porous matrix. The healing behavior corresponds to that of autologous bone grafts.
Inventors
- 👤 Berthold Dr. Nies
- 👤 Elvira Dr. Dingeldein
- 👤 Helmut Dr. Wahlig
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-24 13:09
CPC Classifications
A; A61; A61L; A61L15/00; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61F; A61F2/00; A61F2/02; A61F2/28; A61L27/50; A61L27/56; A61F2/30; A61F2/30767; A61F2002/2817; A61F2/3094; A61F2002/30968; A61L2430/00; A61L2430/02
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.